Suntory Holdings Ltd. will soon commercially use the plastic bottles it developed with US biotechnology startup Anellotech Inc entirely from plant-derived material.
The eco-friendly bottles will be used for all of Suntory’s plastic containers by 2030.
Unlike most plastic bottles in the market, which are made only from petroleum, Suntory’s plant-based bottles use such substances as wood chips.
In 2020, Suntory used 290,000 tons of plastic bottles in and outside Japan, with recycled ones accounting for around 15 percent while those made in part from botanical material comprising seven percent.
Thirty percent of ingredients for containers used for Suntory Tennensui natural mineral water came from sugar cane molasses. In Suntory’s latest endeavor, the remaining 70 percent of the ingredients made from petroleum were replaced with wood chips, making the bottle exclusively plant-based.


Asian Markets Slip as Precious Metals Cool, Geopolitical Tensions Weigh on Sentiment
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Gold Prices Rebound in Europe as Geopolitical Tensions and Fed Outlook Support Bullion
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
U.S. Stock Index Futures Steady as Markets Await Fed Policy Clues in Holiday-Thinned Trade
China Imposes 55% Tariff on Beef Imports Above Quota to Protect Domestic Industry
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
U.S. Dollar Slides Toward Biggest Annual Loss Since 2017 as 2026 Risks Loom
Asian Stock Markets Trade Narrowly as Year-End Volumes Thin, KOSPI Outperforms on Tech Rally
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Gold Prices Ease After Record Highs as Dollar Firms, Broader Bullish Outlook Intact 



